|
|||||||||
|
|
Ixel (Milnacipran)Manufacturer: Pierre Fabre | Active Ingredient: Milnacipran | Origin: France | Other Name: n/a Ixel (Milnacipran) is one of the newer antidepressants on the market. Dosage & Administration Information: The recommended dose is 50 mg twice daily. Best is to take the medication in the mornings with breakfast and in the evenings with dinner. How does Ixel works: Certain brain chemicals (neurotransmitters) are related to the cause of depression. This includes the neurotransmitters serotonin and norepinephrine. Researchers showed that abnormalities in the activity of these neurotransmitters do affect mood and behavior of people. The generic ingredient of Ixel, milnacipran, acts at the same time on these two neurotransmitters. Basically this action is known under the term Serotonin and norepinephrine reuptake inhibitors, short SNRIs. SNRIs increase the levels of both serotonin and norepinephrine by inhibiting their reabsorption (reuptake) into cells in the brain. It is believed that these higher levels raise up neurotransmission (sending of nerve impulses) — and so control and improve mood, depression and pain. Drugs like Ixel are often also called dual reuptake inhibitors. Side Effects: As any other drug the agent milnacipran can create unwished side effects. Against this, not everybody who uses this medication will realize them. Even more, in most of the cases people accept Ixel comparatively well. In the event of side effects do appear, in most cases, these are insignificant and do not demand therapy. To the greatest extend they shall be easily treated by yourself or by your physician.
Precautions: Such symptoms as insomnia and nervousness at the beginning of the treatment may make a temporary symptomatically therapy necessary. Beyond that Ixel should be used over carefully in cases of:
Further Advice: Ixel is not recommended for the use of elderly people. Beyond that it is not advised to give the medication to children and people under the age of 18.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||